Table 1.
Demographics of analyzed patients and lost to follow-up patients.
| Analyzed n=82 (85%) |
Lost to follow-up n=15 (15%) |
p-value | |
|---|---|---|---|
|
| |||
| Age | |||
| >5 years | 54 (66) | 11 (73) | |
| ≤5 years | 28 (34) | 4 (27) | 0.57 |
|
| |||
| Gender | |||
| Female | 23 (28) | 6 (40) | |
| Male | 59 (72) | 9 (60) | 0.35 |
|
| |||
| Race | |||
| White | 59 (72) | 10 (67) | |
| Non-White | 21 (26) | 4 (27) | |
| Missing | 2 (2) | 1 (6) | 0.67 |
|
| |||
| Ethnicity | |||
| Non-Hispanic | 74 (90) | 11 (73) | |
| Hispanic | 8 (10) | 4 (27) | 0.07 |
|
| |||
| Medical conditions | |||
| No | 70 (85) | 12 (80) | |
| Yes | 12 (15) | 3 (20) | 0.60 |
|
| |||
| Anxiety | |||
| Low | 49 (60) | 8 (53) | |
| High | 33 (40) | 7 (47) | 0.64 |
|
| |||
| Sedation duration | |||
| >30 minutes | 69 (84) | 14 (93) | |
| ≤30 minutes | 13 (16) | 1 (7) | 0.35 |
|
| |||
| Midazolam given | |||
| No | 75 (91) | 14 (93) | |
| Yes | 7 (9) | 1 (7) | 0.81 |